NSE · AARTIDRUGS.NS
Aarti Drugs Limited
₹440.30-₹8.70 (-1.94%)
Aarti Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 17.48% below the high.
Loading market information…
BSE · SMRUTHIORG.BO · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:33 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Smruthi Organics Limited’s quoted price sits in the upper half of its reported 52-week range, 20.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Smruthi Organics Limited’s forward annual dividend is ₹1.50 per share, paid annual. The forward yield is 1.07% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Smruthi Organics Limited’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Smruthi Organics Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Smruthi Organics Ltd. primarily focuses on the production and commercialization of bulk pharmaceutical ingredients and their chemical intermediates. The company's product range includes a variety of compounds such as amlodipine besilate, amisulpride, carbidopa, ciprofloxacin, diloxanide furoate, fenofibrate, metformin hydrochloride, norfloxacin, pefloxacin, telmisartan, amlodipine base, and phthaloyl amlodipine. This enterprise was established on July 11, 1989, by Purushotham Mallayya Eaga and is based in Solapur, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹440.30-₹8.70 (-1.94%)
Aarti Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 17.48% below the high.
₹362.00-₹47.80 (-11.66%)
Ind-Swift Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.09% below the high.
₹305.00-₹7.85 (-2.51%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.55% below the high.
₹231.30-₹10.20 (-4.22%)
Everest Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 56.88% below the high.
₹33.75-₹1.51 (-4.28%)
Syschem (India) Limited’s quoted price sits in the lower half of its reported 52-week range, 44.63% below the high.
₹47.92+₹0.06 (+0.13%)
Oxygenta Pharmaceutical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.06% below the high.
₹31.20+₹0.75 (+2.46%)
Kimia Biosciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.91% below the high.
₹232.65-₹0.10 (-0.04%)
Auro Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 26.61% below the high.
